A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers

Name: A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers
Published: 2011
License: Public Domain

GlaxoSmithKline · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

cancer multiple-myeloma oncology

cancer, oncology, solid tumors, multiple myeloma, akt inhibitor, mek inhibitor, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers

Related documents